InvestLog
SOPH SOPHiA GENETICS S.A. logo

SOPH SOPHiA GENETICS S.A.

Healthcare
$4.88-3.37%ClosedMarket Cap: $349.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

7.60

P/S

4.31

EV/EBITDA

-5.25

DCF Value

$-24.84

FCF Yield

-13.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

67.3%

Operating Margin

-88.4%

Net Margin

-99.7%

ROE

-140.6%

ROA

-51.6%

ROIC

-63.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$21.7M$-19.3M$—
Q4 null$21.7M$-19.2M$—
FY null$77.3M$-79.0M$—
Q3 null$19.5M$-20.0M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$7.50

Target (Median)

$7.50

Target Range

$7.00 - $8.00

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
BTIGBuy
2026-05-06
GuggenheimBuy
2026-01-26
BTIGBuy
2025-11-10

Trading Activity

Insider Trades

View All
Xu Zhenyuofficer: Chief Scientific Officer
SellWed May 20
Van Well Daanofficer: Chief Legal Officer
SellWed May 20
Valente Manuelaofficer: Chief People Officer
SellWed May 20
Puylaert Kevinofficer: Chief Sales Officer
SellWed May 20
Muken Rossofficer: President
SellWed May 20

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

CH

Exchange

—

Beta

1.01

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Peers

ACIU logoACIUAGL logoAGLANRO logoANROCLLS logoCLLSDH logoDHLRMR logoLRMRNAKA logoNAKANRC logoNRCOPRX logoOPRXSLP logoSLP